Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: McKesson Corporation (MCK) Report Updated: Apr 14, 2014 | Print This Page

Get more stock ratings by Louis Navellier

McKesson Corporation (MCK)

Rating: Strong Buy Volatility: Conservative
Total Grade: A Industry: Health Care Providers & Services
Competitors: CRVL, EXAM, AIQ, KND
service keys

McKesson Corporation© quotemedia

Company Profile

McKesson Corporation delivers medicines, pharmaceutical supplies, information, and care management products and services for the healthcare industry. The company’s Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment, and health and beauty care products in North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; sells financial, operational and clinical solutions for pharmacies, such as retail, hospital, and alternate sites; and provides consulting and outsourcing services; and sells automated pharmacy and supply management systems and services to retail and institutional outpatient pharmacies. Its Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, and pharmacy automation solutions for hospitals, as well as connectivity, outsourcing, and other services comprising remote hosting and managed services to healthcare organizations. This segment also consists of InterQual clinical criteria solution; medical management tools; claims payment solutions; and care management programs. Its customers include hospitals, physicians, homecare providers, retail pharmacies, and payers from North America, the United Kingdom, Ireland, other European countries, and Israel. The company was founded in 1833 and is headquartered in San Francisco, California.

Recent News: McKesson Corporation